Operose Advisors’s Medpace MEDP Stock Holding History

Operose Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30	Closed	-$14.4K	–	616
2026 Q1	$14.4K	Sell	30 -70	-70%	-$35.8K	﹤0.01%	393
2025 Q4	$56.2K	Buy	+100	New	+$56.8K	0.01%	271

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Operose Advisors's MEDP Position: Q2 2026 in Review

Operose Advisors sold out of Medpace (MEDP) in Q2 2026, closing a stake of 30 shares — an estimated $14.4K sold.

Operose Advisors first reported a position in MEDP in Q4 2025 and held it in 2 quarters. The position peaked at $56.2K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Operose Advisors reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
Operose Advisors sold 30 Medpace shares in Q2 2026, an estimated $14.4K.
Operose Advisors first reported a position in Medpace in Q4 2025 and held it in 2 quarters.
Operose Advisors's Medpace position peaked at $56.2K in Q4 2025.
695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.